Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis

被引:7
|
作者
Balmuri, Nayimisha [1 ,2 ]
Soulsby, William Daniel [3 ]
Cooley, Victoria [2 ]
Gerber, Linda [2 ]
Lawson, Erica [3 ]
Goodman, Susan [1 ,2 ]
Onel, Karen [1 ,2 ]
Mehta, Bella [1 ,2 ]
机构
[1] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[2] Weill Cornell Med, New York, NY 10065 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
HEALTH DISPARITIES; RADIOGRAPHIC PROGRESSION; SOCIOECONOMIC MEASURES; DISEASE OUTCOMES; CHILDREN; CARE; ACCESS; DELAY;
D O I
10.1186/s12969-021-00610-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: The impact of social determinants of health on children with polyarticular juvenile idiopathic arthritis (pJIA) is poorly understood. Prompt initiation of treatment for pJIA is important to prevent disease morbidity; however, a potential barrier to early treatment of pJIAs is delayed presentation to a pediatric rheumatologist. We examined the impact of community poverty level, a key social determinant of health, on time from patient reported symptom onset to first pediatric rheumatology visit among pJIA patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. Methods: This is a cohort study of pJIA patients in the CARRA registry who lived in the United States from July 2015-February 2020. The primary exposure was community poverty level derived by geocoding patient addresses. The primary outcome was time to first rheumatology appointment. Kaplan-Meier analysis was performed to analyze time to first rheumatologist visit, stratified by community poverty and family income. Log-rank tests were used to identify differences between groups. Adjusted cox proportional-hazards models were used to determine the relationship between community poverty level and time from onset of disease symptoms to date first seen by rheumatologist. Results: A total of 1684 patients with pJIA meeting study inclusion and exclusion criteria were identified. Median age of onset of pJIA was 7 years (IQR 3, 11), 79% were female, 17.6% identified as minority race and/or ethnicity, and 19% were from communities with >= 20% community poverty level. Kaplan-Meier analysis by community poverty level (< 20% vs >= 20%) yielded no significant differences with time to initial presentation to a pediatric rheumatologist (p = 0.6). The Cox proportional hazards model showed that patients with >= 20% community poverty level were 19% less likely (adjusted HR 0.81, 95% CI 0.67-0.99, p = 0.038) to be seen by a rheumatologist compared to patients with < 20% community poverty level, at the same time point, after adjusting for sex, race/ethnicity, insurance, education level, morning stiffness, RF status, and baseline CHAQ. Conclusion: In this study of pJIA patients in the CARRA registry, increased community poverty level is associated with longer time to presentation to a pediatric rheumatologist after symptom onset.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis
    Nayimisha Balmuri
    William Daniel Soulsby
    Victoria Cooley
    Linda Gerber
    Erica Lawson
    Susan Goodman
    Karen Onel
    Bella Mehta
    Pediatric Rheumatology, 19
  • [2] Social Determinants of Health and Time to First Pediatric Rheumatology Appointment in Polyarticular Juvenile Idiopathic Arthritis
    Balmuri, Nayimisha
    Cooley, Victoria
    Gerber, Linda
    Goodman, Susan
    Mehta, Bella
    Onel, Karen
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [3] PHARMACOKINETICS OF UPADACITINIB IN PEDIATRIC PATIENTS WITH POLYARTICULAR COURSE JUVENILE IDIOPATHIC ARTHRITIS
    Qian, Y.
    Shmagel, A.
    Hao, S.
    Horneff, G.
    Brunner, H.
    Camp, H.
    Liu, W.
    Mohamed, M. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 666 - 667
  • [4] PEDIATRIC RHEUMATOLOGY IN SOUTHEAST ASIA: JUVENILE IDIOPATHIC ARTHRITIS IN SINGAPORE
    Das, L.
    Hoh, S. F.
    Tan, J.
    Arkachaisri, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 741 - 741
  • [5] Pediatric rheumatology for the adult rheumatologist II - Uveitis in juvenile idiopathic arthritis
    Wright, Tracey
    Cron, Randy Q.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2007, 13 (04) : 205 - 210
  • [6] Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans for New-Onset Polyarticular Juvenile Idiopathic Arthritis
    Ringold, Sarah
    Weiss, Pamela F.
    Colbert, Robert A.
    DeWitt, Esi Morgan
    Lee, Tzielan
    Onel, Karen
    Prahalad, Sampath
    Schneider, Rayfel
    Shenoi, Susan
    Vehe, Richard K.
    Kimura, Yukiko
    ARTHRITIS CARE & RESEARCH, 2014, 66 (07) : 1063 - 1072
  • [7] Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
    Kimura, Yukiko
    Schanberg, Laura E.
    Tomlinson, George A.
    Riordan, Mary Ellen
    Dennos, Anne C.
    Del Gaizo, Vincent
    Murphy, Katherine L.
    Weiss, Pamela F.
    Natter, Marc D.
    Feldman, Brian M.
    Ringold, Sarah
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (10) : 1898 - 1909
  • [8] Factors Impacting Referral of Juvenile Idiopathic Arthritis Patients to a Tertiary Level Pediatric Rheumatology Center in North India
    Freychet, Caroline
    Agarwal, Manjari
    Mittal, Sumidha
    Shivpuri, Abhay
    Singh, Anju
    Dinand, Veronique
    Sawhney, Sujata
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [9] The importance of transition from pediatric to adult rheumatology care in juvenile idiopathic arthritis
    de Oliveira, Rodrigo Joel
    Kishimoto, Simone Thiemi
    de Souza, Debora Pessoa
    Fernandes, Paula Teixeira
    Marini, Roberto
    Appenzeller, Simone
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2021, 17 (02) : 155 - 161
  • [10] Access to pediatric rheumatology care for Juvenile Idiopathic Arthritis in the United Arab Emirates
    Khawaja, Khulood
    Al-Maini, Mustafa
    PEDIATRIC RHEUMATOLOGY, 2017, 15